19:00 - 22:00

Welcome reception drinks & snack 

• Bar Ameron (on generous invitation by BioGenius)

09:00 - 09:10 

Welcome and Opening

• Dr. Florian H. H. Brill & Alexander Brux

BPR Data Packages: Risk assessment, residual test and other data packages. An Update of requirements and challenges today
Chair: Dr. Michael Werner, Bielefeld

• Current challenges and New Pitfalls in Human Health Risk Assessment for Biocides, Dr. Volker Mostert, Langenfeld
• BPR: expectations meet reality. A consultant view, Dr. Maren Lillich, Bad Kreuznach
• Efficacy testing of biocidal products on surfaces against insects - methodology and its challenges, Martin Tomakidi, Dr. Fabian Müller, Bergisch Gladbach
• Keeping track of the BPR maze: How to master data generation and how it all relates to product assessment, Kai Dettmer, Hamburg

Panel discussion: 25 years Biocidal Regulation – Lessons learned and Outlook
Moderator: Dr. Michael Werner

• Panelists:
  - Christoph Zutz, Kwizda Agro, Vienna
  - Dr. Volker Mostert, EXTERA, Langenfeld
  - Heike Schimmelpfennig, Dr. Brill Regulatory Services, Hamburg
  - Mike Bublitz, BioGenius GmbH, Bergisch Gladbach

Keynote Lecture Professor Dr. Ojan Assadian, Vienna
Relevance for Applied Hospital Hygiene from Hospital Management view

Session: Hot topic Infection Prevention & Control
Chairs: Professor Dr. Eike Steinmann, Bochum and Professor Dr. Jörg Steinmann, Nuremberg

• Disinfection profiles of (re-)emerging viruses, Dr. Toni Luise Meister, Hamburg
• COVID-19 – From rapid prevention to understanding disease mechanisms, Prof. Dr. Stephanie Pfänder, Hamburg
• Alongshan virus: An Emerging Segmented Flavivirus with Human Tropism, Dr. André Gömer, Bochum 
• Hidden transmissions - results from longitudinal epidemiology of environmental and clinical isolates, Professor Dr. Johannes Knobloch, Hamburg

Keynote Lecture Professor Dr. Rasmus Leistner, Berlin
Environmental cleaning with probiotic-based agents - opportunities and risks in the prevention of nosocomial infections

Keynote Lecture Dr. Florian H. H. Brill, Hamburg
Overview of development of efficacy testing of disinfectants, antiseptics, wound dressings, and antimicrobial surfaces 2030

Session Resistance Development
Chair: Professor Dr. Jörg Steinmann, Nuremberg

• Development and testing of Resistance Development, Professor Dr. Laurent Piorel, Fribourg (CH)
• Efficacy of laundry disinfection procedures against Candida auris More resistant than other Candida?, Dr. Britta Brands, Kleve
• Efficacy of surface disinfectants against different Candida auris clades, Henrik Gabriel, Hamburg

Session Biofilm Activity testing & Medical Devices, Chair: Dr. Matthias Buhmann, Hamburg

• Relevance of and testing against Biofilms in flexible Endoscopes, Dr. Lionel Pineau, Marseille
• Drain Hygiene – Using a small-scale biofilm model to test the activity of a drain disinfection procedure in a practice-relevant assay, Nicole van Leuven, Kleve
• Biofilms and Regulations – What is going on and what is coming?, Paulina Rakowska

14:00 - 15:30

Practice-like activity tests for biocidal Products and their regulatory Impact
Chairs: Dr. Kerstin Walendy-Gnirss, Dr. Gunnar Kleist, Hamburg

• Role and responsibilities of Regulatory Affairs in the disinfectant marketing process” Dr. Gunnar Kleist, Hamburg:
• Surface and air stability of norovirus in bathrooms: practice-based testing of domestic hygiene product efficacy, Justyna Konkol, Bremen
• Evaluation of Residual Activity in Common Skin Antiseptic Actives Using the IMS Vitro-Skin Model, Dr. Marven Lee, Kuala Lumpur